Idexx Laboratories (IDXX) Share-based Compensation (2009 - 2026)

Idexx Laboratories (IDXX) has reported Share-based Compensation for 18 consecutive years, with $16.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Share-based Compensation rose 11.8% year-over-year to $16.3 million; the TTM figure through Mar 2026 stood at $61.7 million (up 2.03% YoY), while the FY2025 annual figure was $60.0 million, changed 0.47% from the prior year.
• Share-based Compensation came in at $16.3 million for Q1 2026 at Idexx Laboratories, up from $16.1 million in the prior quarter.
• The five-year high for Share-based Compensation was $16.3 million in Q1 2026, with the low at $11.2 million in Q1 2022.
• Average Share-based Compensation over 5 years is $14.5 million, with a median of $14.6 million recorded in 2025.
• Across the five-year window, Share-based Compensation jumped 36.71% in 2022 and dropped 9.33% in 2025, its largest moves.
• Year by year, Share-based Compensation stood at $13.3 million in 2022, then increased by 14.64% to $15.2 million in 2023, then fell by 6.34% to $14.3 million in 2024, then climbed by 13.0% to $16.1 million in 2025, then grew by 1.42% to $16.3 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $16.3 million, $16.1 million, and $14.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.